Open Access

Artemia salina as a model organism in toxicity assessment of nanoparticles

DARU Journal of Pharmaceutical Sciences201523:20

https://doi.org/10.1186/s40199-015-0105-x

Received: 6 September 2014

Accepted: 16 February 2015

Published: 24 February 2015

Abstract

Background

Because of expanding presence of nanomaterials, there has been an increase in the exposure of humans to nanoparticles that is why nanotoxicology studies are important. A number of studies on the effects of nanomatrials in in vitro and in vivo systems have been published. Currently cytotoxicity of different nanoparticles is assessed using the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay on different cell lines to determine cell viability, a tedious and expensive method. The aim of this study was to evaluate the Artemia salina test in comparison with the MTT assay in the assessment of cytotoxicity of nanostructures because the former method is more rapid and convenient and less expensive.

Methods

At the first stage, toxicity of different nanoparticles with different concentrations (1.56–400 μg/mL) was measured by means of the brine shrimp lethality test. At the second stage, the effect of nanoparticles on the viability of the L929 cell line was assessed using the MTT assay. Experiments were conducted with each concentration in triplicate.

Results

The results obtained from both tests (A. salina test and MTT assay) did not have statistically significant differences (P > 0.05).

Conclusions

These findings suggest that the A. salina test may expedite toxicity experiments and decrease costs, and therefore, may be considered an alternative to the in vitro cell culture assay.

Keywords

Artemia salina Toxicity Nanoparticle Cell culture

Background

Nanoscience is a novel science that is being developed to probe and manipulate matter on the scale of single atoms and molecules. Physicist Richard P. Feynman was the first to mention molecular machines built with atomic precision at a meeting of the American Physical Society in 1959 [1], and Noro Taniguchi, a professor at the University of Tokyo, coined the term nanotechnology in 1979 [2]. Nanotechnology is the use of nanoscience to design NMs (nanomaterials) and NPs (nanoparticles), with structural components between 1 and 100 nanometers; it is thought to be one of the key technologies of the 21st century [3,4]. In the above range, physicochemical characteristics of NPs in biological systems can vary. Some potential hazards have been identified in the life cycle of NMs and NPs [5,6]. Growing research and development in nanotechnology have resulted in the identification of many unique properties of nanomaterials such as enhanced magnetic, catalytic, optical, electrical, and mechanical properties when compared to conventional formulations of the same materials [7]. While nanoparticles have a wide variety of functions, there has been increasing issues and debate amongst the regulatory and scientific community regarding the fate of nanoparticles in biological systems and associated side effects these agents might have on living organisms [8-12]. These materials are increasingly used for commercial purposes and leading to direct and indirect exposure of humans [13]. Any in vivo use of nanoparticles requires thorough understanding of the kinetics and toxicology of the particles, establishment of principles and test procedures to ensure safe manufacture and usage of nanomaterials, and comprehensive training of personnel in safety and potential hazards of nanotechnology [13]. Nanotoxicology research is applied to various fields including biology and pathology, but typically to pharmacology and to the use of NMs and nanodevices for diagnostic and therapeutic purposes. Therefore, a key goal for toxicologists is to identify in vitro and in vivo assays accurately reflecting the ability of NPs to induce toxic effects in the humans and in the environment. In addition, standardized tests for both in vitro and in vivo studies are needed to develop better and more rapid screening techniques and to predict toxicity [14,15]. The cytotoxicity effects of NPs were investigated in a multitude of animal models by means of in vivo tests employing the typical NP exposure routes, i.e., pulmonary, oral, dermal, and injection based [16]. The cost and labor intensiveness of the in vivo studies have led researchers to the use of in vitro methods for assessment of NPs cytotoxicity. In addition, animal rights advocates have criticized the use of animals in nanotechnology experiments. All in vivo studies must be conducted with the approval of regulatory bodies such as IACUC (an Institutional Animal Care and Use Committee) to ensure ethical treatment of animals [16]. For the above reasons, in vitro techniques are increasingly used for the analysis of cytotoxicity of NPs including cell culture, the WST-1 assay [17,18], XTT assay, MTT assay [19,20], LDH assay, BrdU assay, and fluorescence microscopy [21,22]. Currently, cytotoxicity testing of various NPs in cell culture involves the MTT assay, which determines cell viability based on mitochondrial function by measuring the activity of mitochondrial enzymes [23-27]. In this test, tetrazolium is reduced by mitochondrial succinate dehydrogenase of live cells to water-insoluble purple formazan crystals, which are subsequently solubilized using an organic solvent (e.g., dimethyl sulfoxide; DMSO) [28]. The cell viability is quantified based on absorbance of the solution at 570 nm. Therefore, the MTT assay requires solubilization steps with tetrazolium, which is toxic to cells and can interfere with some chemical reactions [28]. The cytotoxicity assays are often tedious and expensive, and there is a lack of a simple and rapid screening procedure. Nowadays, brine shrimp lethality assays are extensively used in research and applied toxicology [29]. There is a tendency to use an Artemia salina assay in toxicological tests that screen a large number of extracts for drug discovery in medicinal plants [30-33]. This is because in this case, aseptic techniques are not required, and thus A. salina assays could replace the more ethically challenging MTT assay that requires animal serum [34]. This assay was proposed by Michael and coworkers in 1959 and was later adopted by many laboratories as a method for preliminary estimation of toxicity [35]. Artemia is one of the most valuable test organisms available for ecotoxicity testing, and the available research suggests that several applications of Artemia to toxicology and ecotoxicology will continue to be used widely [36]. Because of the rapidity, convenience, and low cost of Artemia-based assays, we decided to evaluate the A. salina test in comparison with the MTT assay in the assessment of cytotoxicity of different classes of NPs.

Materials and methods

Materials

Fetal bovine serum (FBS), phosphate-buffered saline (PBS), trypsin, penicillin, streptomycin, DMSO, 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyl tetrazolium bromide (MTT), Triton X-100, and the RPMI-1640 medium supplemented with 10% heat inactivated FBS were purchased from Sigma–Aldrich. The mouse fibroblast cell line (L929) was provided by Pasteur Institute of Iran.

Synthesis of NPs

Sixteen NPs from different classes (Table 1) were prepared by the Nanotechnology Laboratory of School of Pharmacy of Zanjan University of Medical Sciences. The zeta potential and particle size distribution of the prepared nanoparticles were determined by photon correlation spectroscopy (PCS) using a Nano/zetasizer (Malvern Instruments, Nano ZS, Worcestershire, UK) working on the dynamic light scattering (DLS) platform.
Table 1

Names and characteristics of NPs used in this study

NPs class

NPs name

Size NPs (nm)

Zeta potential (mV)

Inorganic nanoparticles

Magnetic

55

- 31

Nanosfer

97

+8.9

Lipid-base nanoparticles

Liposome

139.3

- 28

Coated SLNs

464.6

+20

Uncoated SLNs

176.3

- 45

Nanogele + SLN

376.6

+4

Polymeric nanoparticles

Nanogele

270

+22

Micellar

97.9

- 1.10

PAMAM (G5)

6

+36.8

PAMAM-FA

55

+36.4

PAMAM-PEG-FA

70

9.12

Drug nanoparticles

Nanosuspansion Atorvastatin

269.8

ND

Nanosuspansion Ibuprofen

160.9

ND

Nanosuspansion Repaglinide

260.6

ND

Nanosuspansion Cyclosporin

220.5

ND

Nanosuspansion Azitromycin

270

ND

ND; not determined.

Cell culture and determination of cytotoxicity by MTT assay

The effect of NPs on the viability of L929 cells was assessed by means of the MTT assay. After thawing, the cells were cultured in the RPMI 1640 medium containing 10% FBS, penicillin (100 units/mL), and streptomycin (100 mg/mL) at 37°C in a humidified 5% CO2 incubator. The cells were seeded in a 96-well plate at a density of 5,000 cells per well (the cells were stained with trypan blue and counted with haemocytometer). These cells were incubated overnight at 37°C before the cell viability test. A stock suspension of each NP at 50 mg/mL in distilled water was prepared. After that, fresh suspensions of different concentrations of NPs (two fold serial dilutions from 1.56–400 μg/mL) were made using serial dilution of the stock suspensions of NPs in the RPMI 1640 medium, immediately before use. We added 200 μL of a suspension (different concentrations of NPs) to each well of the microtiter plates. The cells were incubated for 24 h under the same conditions. Wells without any NPs served as a negative control. The experiments were performed in triplicate for each concentration. To assess cell survival, 100 μL of an MTT solution (2 mg/mL in PBS) was added to each well and incubated for 3 h at 37°C to produce insoluble formazan. Then, 100 μL of DMSO was added to dissolve formazan crystals, and the absorbance was measured on an Infinite M200 microplate reader (Tecan) at 570 nm, with 630 nm as a reference wavelength. The percentage of cell viability was calculated using the formula (Atest/Acontrol) × 100, where Atest is the mean absorbance of treated cells and Acontrol is the mean absorbance of a negative control.

Toxicity testing by A. salina

A. salina eggs were purchased from the Aquatic Animal Research Center, Urmia University, Urmia, Iran. Dried cysts were placed in a bottle containing artificial sea water which was prepared by dissolving 35 g of sodium chloride in 1 L of distilled water. After 36–48 h incubation at room temperature (28–30°C) under conditions of strong aeration and continuous illuminations [33], the larvae (nauplii) hatched within 48 h.

The evaluation of cytotoxicity of NPs in A. salina was performed according to the previous methods [30,33,37,38]. The assay was carried out on larvae of brine shrimp (A. salina Leach.). A stock solution of 50 mg of nanoparticles in 1 mL of distilled water was prepared. Then, fresh suspensions with different concentrations of NPs (two fold serial dilutions from 1.56–400 μg/mL) were made by means of serial dilution of the stock suspensions of NPs in artificial sea water (35 g/L) immediately before use. We added 200 μL of a suspension (different concentrations of NPs) to each well of the 96-well microtiter plates. After that, 10 nauplii per well were added in the 96-well plates and incubated at room temperature for 24 h. The numbers of surviving nauplii in each well were counted under a stereoscopic microscope after 24 h. The experiments were conducted in triplicate for each concentration. The negative control wells contained 10 nauplii and artificial sea water only. The percentages of deaths were calculated by comparing the number of survivors in the test and control wells. The lethality was calculated using Abbott’s formula as follows:% Lethality = [(Test − Control)/Control] × 100.

Statistical analysis

All experiments were done in triplicate and the results were calculated as a mean ± standard deviation (SD). The experimental data were processed using the paired sample t-test, Pearson correlation and linear regression analysis of the SPSS version 16.0 software for Windows. The toxicity of each nanoparticle was calculated from the 50% lethality dose (LD50) by means of Finney’s Probit analysis [39].

Results

Cytotoxicity of nanostructures by the MTT assay

The MTT assay is a viable method for assessing in vitro cytotoxicity of NPs. In this study, L929 cells were treated with different concentrations (0.78–200 μg/mL) of the 16 NPs (Table 1). Cell viability was determined 24 hours after the treatment. The results are presented in Table 2. Uncoated solid lipid nanoparticles (SLNs), Nanogel + SLN, Bare Nanogel, polyamidoamine (PAMAM; G5), and PAMAM-FA demonstrated moderate cytotoxicity. In contrast, the NPs with IC50 > 200 μg/mL were not toxic to the L929 cell line. The cytotoxicity was weak when the IC50 values were between 150 and 200 μg/mL.
Table 2

NPs toxicity assay by Artemia salina and MTT assay

NPs name

Artemia salina assay, LC 50 (μg/m)

95% confidence limits for concentration

MTT assay, IC 50 (μg/ml)

95% confidence limits for concentration

Lower bound

Upper bound

Lower bound

Upper bound

Magnetic

698.710

431.764

2669.870

997.402

527.931

3340.601

Nanosfer

302.001

215.853

497.009

207.431

141.862

365.065

Liposome

751.249

432.851

6492.955

1002.666

543.931

4358.603

Coated SLNs

360.594

285.519

501.000

605.594

472.900

1248.021

Uncoated SLNs

239.040

192.979

310.917

149.018

90.886

328.486

Nanogele + SLN

19.656

15.141

24.908

113.903

58.153

380.573

Nanogele

40.440

8.221

95.196

130.171

77.672

285.277

Micellar

560.060

352.592

1801.667

686.002

263.396

1329.851

PAMAM (G5)

145.6

60.435

671.764

72.254

41.149

139.077

PAMAM-FA

213.316

185.467

839.316

99.783

61.360

130.925

PAMAM-PEG-FA

401.21

256.482

1002.310

270.585

129.042

496.556

Nanosuspansion Atorvastatin

417.349

272.658

1046.615

807.668

301.840

1080.114

Nanosuspansion Ibuprofen

373.526

285.877

559.357

156.433

117.536

244.043

Nanosuspansion Repaglinide

807.754

488.424

4335.993

297.756

221.995

527.574

Nanosuspansion Cyclosporin

531.961

368.036

1095.239

167.965

108.493

230.459

Nanosuspansion Azitromycin

110.316

57.555

231.560

162.512

168.114

249.652

Cytotoxicity of nanostructures in the brine shrimp assay

The brine shrimp lethality assay was also used to determine the cytotoxicity of NPs. According to the results (Table 2), of the 16 NPs that we screened for lethality in A. salina, only two NPs (Nanogel + SLN and Nanogel) showed strong toxicity (LC50 < 100 μg/mL). In contrast, NPs of Uncoated SLN, PAMAM (G5), Nanosuspension Ibuprofen, and Nanosuspension Azithromycin exhibited moderate cytotoxicity (LC50 ranged between 100 and 500 μg/mL), and the other NPs showed weak cytotoxicity in A. salina (LC50 range 500–1000 μg/mL) [37,40]. Comparison between the results of two methods is indicated in Figure 1. As shown in Figure 1, the trend lines and the direction of the graphs are in same direction.
Figure 1

Comparison of Artemia salina and MTT assay results

Discussion

Several assays for eco-toxicological testing of nanomaterials have been developed. Different model systems such as bacteria [41], fathead minnows [42], zebrafish embryos [43], copepod [44], Daphnia [45,46], and rainbow trout [47,48] have been reported [49]. In addition to standard tests, there is a need to establish better, rapid and convenient methods to predict the toxic effects of nanomaterials. Till now, A few studies have reported the toxicity effect of nanomaterials on A. salina [38,50-52]. These studies were investigated on metal nanoparticles and we want develop the A. salina assay for toxicity assessment of different class of nanomaterials especially those used for drug deliveries.

In this work, cytotoxicity of 16 NPs was assessed using two methods: the brine shrimp lethality assay and the MTT assay in L929 cells. According to the results (Figure 1) the correlation between the LC50 and IC50 values is significant (R2 = 0.72, P = 0.000). This mean that 72% variability noted in MTT method could be accounted for by brine shrimp lethality assay and 28% is unaccounted for due to measurement error. There was not statistically significant difference between two assays when the results were compared with paired t test (P = 0.402). Also the comparison between LC50 and IC50 mean values statistically analyzed by chi square test and the result showed that there is no differences between two assay methods (P = 0.235). This mean that results obtained by brine shrimp lethality assay is comparable with MTT results. Both the ranking and the degree of cytotoxicity were similar between the brine shrimp lethality assay and the MTT assay. As it has been shown in Table 2, the ranges of 95% confidence limit are wide. The width of the confidence interval for an individual study depends to a large extent on the sample size. Larger studies tend to give more precise estimates of effects (and hence have narrower confidence intervals) than smaller studies. In order to obtain a more reliable estimate of the confidence interval it may be necessary to perform several independent assays and to combine these into one single confidence interval [53]. The results demonstrate the ability of the brine shrimp lethality assay to accurately quantify cytotoxicity of NPs and to replace the MTT assay, which is expensive and tedious. In this field, cytotoxicity assays and experimental procedures often lack a simple, convenient, and rapid screening method. On the other hand, the brine shrimp lethality assay has been used in toxicology research routinely for over thirty years [36]. The genus Artemia has a several advantages that make it ideal for general toxicity assays including wide geographical distribution, adaptability to extreme conditions, capability to use several nutrient resources, and availability of their cysts for collection [36]. The brine shrimp assay is convenient because it is rapid (24 h), economical, and simple. The eggs of A. salina are readily available at low cost and remain viable for years in dry storage. The assay easily accommodates a large number of nauplii for statistical validation and no special equipment is needed. Moreover, this assay does not require animal serum and thereby it prevents unnecessary use of animals in scientific experiments. In summary, it is possible to measure cytotoxicity of NPs using the brine shrimp lethality assay instead of the common in vitro cell culture assays.

Conclusion

This work shows that the brine shrimp lethality assay can be used to study toxicity of nanostructures. Self-sufficiency and rapid results are important advantages of this method. Artemia-based toxicity assay of NPs are cheap, continuously available, simple and reliable and are thus an important answer to routine needs of toxicity screening, for industrial monitoring requirements or for regulatory purposes. Our data are expected to facilitate pharmacological and nanotoxicological research.

Declarations

Acknowledgments

We thank the research deputy of Zanjan University of Medical Sciences (ZUMS) for financial support of this project.

Authors’ Affiliations

(1)
Cell and Molecular Biology Departments, Pharmaceutical Sciences Branch, Islamic Azad University
(2)
Biotechnology Departments, School of Pharmacy, Zanjan University of Medical Sciences
(3)
Zanjan Pharmaceutical Nanotechnology Research Center, Zanjan University of Medical Sciences

References

  1. Toumey CP. Reading Feynman into nanotechnology. Techné: Res Philos Technol. 2009;12:133–68.Google Scholar
  2. Singh M, Manikandan S, Kumaraguru A. Nanoparticles: a new technology with wide applications. Res J Nanosci Nanotechnol. 2011;1:1–11.View ArticleGoogle Scholar
  3. Lloyd SM, Lave LB, Matthews HS. Life cycle benefits of using nanotechnology to stabilize platinum-group metal particles in automotive catalysts. Environ Sci Technol. 2005;39:1384–92.View ArticlePubMedGoogle Scholar
  4. Yadav A, Ghune M, Jain DK. Nano-medicine based drug delivery system. J Advanced Pharm Educ Res. 2011;1:201–13.Google Scholar
  5. Drobne D. Nanotoxicology for safe and sustainable nanotechnology. Arh Hig Rada Toksikol. 2007;58:471–8.View ArticlePubMedGoogle Scholar
  6. Ikramullah A, Salve D, Pai G, Rathore M, Joshi D. In vitro cytotoxicity testing of silver nano-particals in lymphocyte and sperm cells. Ind J Fund Appl Life Sci. 2013;3:44–7.Google Scholar
  7. Arora S, Rajwade JM, Paknikar KM. Nanotoxicology and in vitro studies: the need of the hour. Toxicol Appl Pharmacol. 2012;258:151–65.View ArticlePubMedGoogle Scholar
  8. Sharma A, Madhunapantula SV, Robertson GP. Toxicological considerations when creating nanoparticle-based drugs and drug delivery systems. Expert Opin Drug Metab Toxicol. 2012;8:47–69.View ArticlePubMed CentralPubMedGoogle Scholar
  9. Hsieh SF, Bello D, Schmidt DF, Pal AK, Rogers EJ. Biological oxidative damage by carbon nanotubes: fingerprint or footprint? Nanotoxicology. 2012;6:61–76.View ArticlePubMedGoogle Scholar
  10. Wessels A, Van Berlo D, Boots AW, Gerloff K, Scherbart AM, Cassee FR, et al. Oxidative stress and DNA damage responses in rat and mouse lung to inhaled carbon nanoparticles. Nanotoxicology. 2011;5:66–78.View ArticlePubMedGoogle Scholar
  11. Mogharabi M, Abdollahi M, Faramarzi M. Toxicity of nanomaterials; an undermined issue. Daru. 2014;22:59.View ArticlePubMed CentralPubMedGoogle Scholar
  12. Mostafalou S, Mohammadi H, Ramazani A, Abdollahi M. Different biokinetics of nanomedicines linking to their toxicity; an overview. Daru. 2013;21:14.View ArticlePubMed CentralPubMedGoogle Scholar
  13. Nel A, Xia T, Madler L, Li N. Toxic potential of materials at the nanolevel. Science. 2006;311:622–7.View ArticlePubMedGoogle Scholar
  14. Dhawan A, Sharma V. Toxicity assessment of nanomaterials: methods and challenges. Anal Bioanal Chem. 2010;398:589–605.View ArticlePubMedGoogle Scholar
  15. Maccormack TJ, Clark RJ, Dang MK, Ma G, Kelly JA, Veinot JG, et al. Inhibition of enzyme activity by nanomaterials: potential mechanisms and implications for nanotoxicity testing. Nanotoxicology. 2012;6:514–25.View ArticlePubMedGoogle Scholar
  16. Suh WH, Suslick KS, Stucky GD, Suh YH. Nanotechnology, nanotoxicology, and neuroscience. Prog Neurobiol. 2009;87:133–70.View ArticlePubMed CentralPubMedGoogle Scholar
  17. Dechsakulthorn F, Hayes A, Bakand S, Joeng L, Winder C. In vitro cytotoxicity assessment of selected nanoparticles using human skin fibroblasts. AATEX. 2007;14:397–400.Google Scholar
  18. Gonzales M, Mitsumori LM, Kushleika JV, Rosenfeld ME, Krishnan KM. Cytotoxicity of iron oxide nanoparticles made from the thermal decomposition of organometallics and aqueous phase transfer with Pluronic F127. Contrast Media Mol Imaging. 2010;5:286–93.View ArticlePubMed CentralPubMedGoogle Scholar
  19. Zanette C, Pelin M, Crosera M, Adami G, Bovenzi M, Larese FF, et al. Silver nanoparticles exert a long-lasting antiproliferative effect on human keratinocyte HaCaT cell line. Toxicol In Vitro. 2011;25:1053–60.View ArticlePubMedGoogle Scholar
  20. Sauer UG, Vogel S, Hess A, Kolle SN, Ma-Hock L, van Ravenzwaay B, et al. In vivo-in vitro comparison of acute respiratory tract toxicity using human 3D airway epithelial models and human A549 and murine 3T3 monolayer cell systems. Toxicol In Vitro. 2013;27:174–90.View ArticlePubMedGoogle Scholar
  21. Decker T, Lohmann-Matthes ML. A quick and simple method for the quantitation of lactate dehydrogenase release in measurements of cellular cytotoxicity and tumor necrosis factor (TNF) activity. J Immunol Methods. 1988;115:61–9.View ArticlePubMedGoogle Scholar
  22. Korzeniewski C, Callewaert DM. An enzyme-release assay for natural cytotoxicity. J Immunol Methods. 1983;64:313–20.View ArticlePubMedGoogle Scholar
  23. Alley MC, Scudiero DA, Monks A, Hursey ML, Czerwinski MJ, Fine DL, et al. Feasibility of drug screening with panels of human tumor cell lines using a microculture tetrazolium assay. Cancer Res. 1988;48:589–601.PubMedGoogle Scholar
  24. Campling BG, Pym J, Baker HM, Cole SP, Lam YM. Chemosensitivity testing of small cell lung cancer using the MTT assay. Br J Cancer. 1991;63:75–83.View ArticlePubMed CentralPubMedGoogle Scholar
  25. Fisichella M, Dabboue H, Bhattacharyya S, Saboungi ML, Salvetat JP, Hevor T, et al. Mesoporous silica nanoparticles enhance MTT formazan exocytosis in HeLa cells and astrocytes. Toxicol In Vitro. 2009;23:697–703.View ArticlePubMedGoogle Scholar
  26. Silva GA. Introduction to nanotechnology and its applications to medicine. Surg Neurol. 2004;61:216–20.View ArticlePubMedGoogle Scholar
  27. Wang H, Cheng H, Wang F, Wei D, Wang X. An improved 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT) reduction assay for evaluating the viability of Escherichia coli cells. J Microbiol Methods. 2010;82:330–3.View ArticlePubMedGoogle Scholar
  28. Berridge MV, Herst PM, Tan AS. Tetrazolium dyes as tools in cell biology: new insights into their cellular reduction. Biotechnol Annu Rev. 2005;11:127–52.View ArticlePubMedGoogle Scholar
  29. Costa-Lotufo LV, Khan MT, Ather A, Wilke DV, Jimenez PC, Pessoa C, et al. Studies of the anticancer potential of plants used in Bangladeshi folk medicine. J Ethnopharmacol. 2005;99:21–30.View ArticlePubMedGoogle Scholar
  30. Kheiri Manjili H, Jafari H, Ramazani A, Davoudi N. Anti-leishmanial and toxicity activities of some selected Iranian medicinal plants. Parasitol Res. 2012;111:2115–21.View ArticlePubMedGoogle Scholar
  31. Ramazani A, Sardari S, Zakeri S, Vaziri B. In vitro antiplasmodial and phytochemical study of five Artemisia species from Iran and in vivo activity of two species. Parasitol Res. 2010;107:593–9.View ArticlePubMedGoogle Scholar
  32. Ramazani A, Zakeri S, Sardari S, Khodakarim N, Djadidt ND. In vitro and in vivo anti-malarial activity of Boerhavia elegans and Solanum surattense. Malar J. 2010;9:124.View ArticlePubMed CentralPubMedGoogle Scholar
  33. Sangian H, Faramarzi H, Yazdinezhad A, Mousavi SJ, Zamani Z, Noubarani M, et al. Antiplasmodial activity of ethanolic extracts of some selected medicinal plants from the northwest of Iran. Parasitol Res. 2013;112:3697–701.View ArticlePubMedGoogle Scholar
  34. Mclaughlin JL, Rogers LL, Anderson JE. The use of biological assays to evaluate botanicals. Drug Inf J. 1998;32:513–24.Google Scholar
  35. Insanu M, Anggadiredja J, Kayser O. Curcacycline A and B–new pharmacological insights to an old drug. Int J Appl Res Nat Prod. 2012;5:26–34.Google Scholar
  36. Nunes BS, Carvalho FD, Guilhermino LM, Van Stappen G. Use of the genus Artemia in ecotoxicity testing. Environ Pollut. 2006;144:453–62.View ArticlePubMedGoogle Scholar
  37. Meyer BN, Ferrigni NR, Putnam JE, Jacobsen LB, Nichols DE, McLaughlin JL. Brine shrimp: a convenient general bioassay for active plant constituents. Planta Med. 1982;45:31–4.View ArticleGoogle Scholar
  38. Ashtari K, Khajeh K, Fasihi J, Ashtari P, Ramazani A, Vali H. Silica-encapsulated magnetic nanoparticles: enzyme immobilization and cytotoxic study. Int J Biol Macromol. 2012;50:1063–9.View ArticlePubMedGoogle Scholar
  39. Finney DJ. The adjustment for a natural response rate in probit analysis. Ann Appl Biol. 1949;36:187–95.View ArticlePubMedGoogle Scholar
  40. Padmaja R, Arun PC, Prashanth D, Deepak M, Amit A, Anjana M. Brine shrimp lethality bioassay of selected Indian medicinal plants. Fitoterapia. 2002;73:508–10.View ArticlePubMedGoogle Scholar
  41. Lyon DY, Fortner JD, Sayes CM, Colvin VL, Hughe JB. Bacterial cell association and antimicrobial activity of a C60 water suspension. Environ Toxicol Chem. 2005;24:2757–62.View ArticlePubMedGoogle Scholar
  42. Zhu S, Oberdorster E, Haasch ML. Toxicity of an engineered nanoparticle (fullerene, C60) in two aquatic species, Daphnia and fathead minnow. Mar Environ Res. 2006;62(Suppl):S5–9.View ArticlePubMedGoogle Scholar
  43. Zhu X, Zhu L, Li Y, Duan Z, Chen W, Alvarez PJ. Developmental toxicity in zebrafish (Danio rerio) embryos after exposure to manufactured nanomaterials: buckminsterfullerene aggregates (nC60) and fullerol. Environ Toxicol Chem. 2007;26:976–9.View ArticlePubMedGoogle Scholar
  44. Templeton RC, Ferguson PL, Washburn KM, Scrivens WA, Chandler GT. Life-cycle effects of single-walled carbon nanotubes (SWNTs) on an estuarine meiobenthic copepod. Environ Sci Technol. 2006;40:7387–93.View ArticlePubMedGoogle Scholar
  45. Hund-Rinke K, Simon M. Ecotoxic effect of photocatalytic active nanoparticles (TiO2) on algae and daphnids. Environ Sci Pollut Res Int. 2006;13:225–32.View ArticlePubMedGoogle Scholar
  46. Roberts AP, Mount AS, Seda B, Souther J, Qiao R, Lin S, et al. In vivo biomodification of lipid-coated carbon nanotubes by Daphnia magna. Environ Sci Technol. 2007;41:3025–9.View ArticlePubMedGoogle Scholar
  47. Smith CJ, Shaw BJ, Handy RD. Toxicity of single walled carbon nanotubes to rainbow trout, (Oncorhynchus mykiss): respiratory toxicity, organ pathologies, and other physiological effects. Aquat Toxicol. 2007;82:94–109.View ArticlePubMedGoogle Scholar
  48. Fraser TW, Reinardy HC, Shaw BJ, Henry TB, Handy RD. Dietary toxicity of single-walled carbon nanotubes and fullerenes (C60) in rainbow trout (Oncorhynchus mykiss). Nanotoxicology. 2011;5:98–108.View ArticlePubMedGoogle Scholar
  49. Ambrosone A, Marchesano V, Mazzarella V, Tortiglione C. Nanotoxicology using the sea anemone Nematostella vectensis: from developmental toxicity to genotoxicology. Nanotoxicology. 2014;8:508–20.View ArticlePubMedGoogle Scholar
  50. Cornejo-Garrido H, Kibanova D, Nieto-Camacho A, Guzman J, Ramirez-Apan T, Fernandez-Lomelin P, et al. Oxidative stress, cytoxicity, and cell mortality induced by nano-sized lead in aqueous suspensions. Chemosphere. 2011;84:1329–35.View ArticlePubMedGoogle Scholar
  51. Ates M, Daniels J, Arslan Z, Farah IO. Effects of aqueous suspensions of titanium dioxide nanoparticles on Artemia salina: assessment of nanoparticle aggregation, accumulation, and toxicity. Environ Monit Assess. 2013;185:3339–48.View ArticlePubMed CentralPubMedGoogle Scholar
  52. Pretti C, Oliva M, Pietro RD, Monni G, Cevasco G, Chiellini F, et al. Ecotoxicity of pristine graphene to marine organisms. Ecotoxicol Environ Saf. 2014;101:138–45.View ArticlePubMedGoogle Scholar
  53. Hong W, Meier P, Deininger R. Estimation of a single probit line from multiple toxicity test data. Aquat Toxicol. 1988;12:193–202.View ArticleGoogle Scholar

Copyright

© Rajabi et al.; licensee BioMed Central. 2015

This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Advertisement